Stimulants | Overdose Prevention | CDC Stimulants include drugs such as methamphetamine, other amphetamines, and cocaine Stimulant-involved overdose deaths have risen in recent years View our Stimulant Guide below to learn more about risks, how to identify a stimulant overdose, and how to access resources for further support or education
Division of Overdose Prevention STIMULANT GUIDE Centers for Disease Control and Prevention A Stimulant Guide: Answers to Emerging Questions about Stimulants in the Context of the Overdose Epidemic in the United States National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, U S Department of Health and Human Services, 2022
MMWR, Volume 74, Issue 32 August 28, 2025 Abstract Drug overdose deaths involving stimulants have increased in the United States since 2011 This report describes charac-teristics of stimulant-involved overdose deaths during January 2021–June 2024 using CDC’s State Unintentional Drug Overdose Reporting System data and trends by drug and race and ethnicity during 2018–2023 using CDC’s National Vital Statistics System data
Vital Signs: Characteristics of Drug Overdose Deaths . . . This report describes characteristics of drug overdose deaths that involved opioids and stimulants during 2019 and how changes to prevention, treatment, and response strategies could help prevent overdose deaths
Products - Data Briefs - Number 549 - January 2026 Drug overdose death rates, including those involving synthetic opioids (such as fentanyl) and stimulants (such as cocaine and methamphetamine) rose over the past several decades in the United States, becoming a topic of national importance (2 – 4)
POLYSUBSTANCE USE FACTS Combining stimulants may even directly of indirectly increase your rise of: brain injury, liver damage, heart attack, stroke benzodiazepines Depressants (also known as downers) can slow down your breathing and increase your risk of several adverse health outcomes
Synthetic Opioid and Stimulant Co-Involved Overdose . . . Understanding occupational differences in the types of stimulants co-involved in synthetic opioid-involved overdose deaths might therefore prove useful for tailoring workplace-oriented overdose prevention efforts (4)